CORTENDO AB PUBL has a total of 25 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are TARGEGEN INC, LAB OS DEL DR EHSTEV S A and SCHWARZ PHARMA S L.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 3 | |
#5 | Australia | 2 | |
#6 | China | 1 | |
#7 | Norway | 1 | |
#8 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Steroids | |
#5 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Childers Wayne E | 11 |
#2 | Blass Benjamin Eric | 11 |
#3 | Abou-Gharbia Magid A | 10 |
#4 | Koziol Theodore Richard | 5 |
#5 | Iyer Pravin | 5 |
#6 | Boruwa Joshodeep | 5 |
#7 | Stewart Timothy Andrew | 4 |
#8 | Marin Per | 3 |
#9 | Reiser H Joseph | 3 |
#10 | Bobbala Ramreddy | 2 |
Publication | Filing date | Title |
---|---|---|
WO2016048984A1 | Methods and compositions for the treatment of cushing's syndrome using 2s, 4r ketoconazole | |
US2015210641A1 | Novel cytochrome p450 inhibitors and their method of use | |
CA2925294A1 | Novel functionalized 5-(phenoxymethyl)-1,3-dioxane analogs exhibitng cytochrome p450 inhibition | |
CA2924168A1 | Novel cytochrome p450 inhibitors and their method of use | |
US2015353530A1 | Novel functionalized 4-(phenoxymethyl(-1,3-dioxolane analogs exhibiting cytochrome p450 inhibition and their method of use | |
CA2898573A1 | Abiraterone and analogs thereof for the treatment of diseases associated with cortisol overproduction |